Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

36%

9 trials in Phase 3/4

Results Transparency

47%

7 of 15 completed with results

Key Signals

7 with results100% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (5)
Early P 1 (1)
P 1 (1)
P 2 (5)
P 3 (4)
P 4 (5)

Trial Status

Completed15
Unknown4
Not Yet Recruiting3
Withdrawn1
Active Not Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07546032Not ApplicableNot Yet RecruitingPrimary

Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy

NCT06578728Phase 4Active Not RecruitingPrimary

Local Methotrexate Injections for the Treatment of Nail Psoriasis

NCT07313072Phase 2Not Yet RecruitingPrimary

Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

NCT07029516Phase 3RecruitingPrimary

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

NCT05124080Early Phase 1CompletedPrimary

An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis

NCT06802848Not Yet Recruiting

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

NCT04227288Phase 4CompletedPrimary

A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis

NCT03991936Phase 4CompletedPrimary

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

NCT06150794Not ApplicableUnknownPrimary

Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis

NCT05695833Not ApplicableUnknownPrimary

Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis

NCT05072886Phase 1UnknownPrimary

Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis

NCT04580537Phase 2CompletedPrimary

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails

NCT04380597CompletedPrimary

Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life

NCT03616561CompletedPrimary

Quality of Life and Ultrasonographic Assessment of Nail Psoriasis After Treatment With Apremilast (JUST Study)

NCT02168933Not ApplicableCompletedPrimary

308nm Excimer Laser for Treatment of Fingernail Psoriasis

NCT01445886Phase 2CompletedPrimary

Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis

NCT00999687Phase 2CompletedPrimary

Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails

NCT03946826Not ApplicableCompletedPrimary

A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis

NCT03757364CompletedPrimary

Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis

NCT02606760Phase 3CompletedPrimary

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis

Scroll to load more

Research Network

Activity Timeline